Scripps Research Institute

AbbVie, Caribou Biosciences Collaborate in CAR-T Cell Deal

Business, CAR-T Therapy, Cell Therapy, Clinical Trials, Collaborations, CRISPR, Deals, Genome Editing, Partnerships, R&D, Scripps Research Institute, Topline Data

AbbVie announced the company’s latest chimeric antigen receptor (CAR)-T cell investment, a collaboration with Caribou Biosciences worth $40 million up front in cash and equity to develop two CRISPR-edited cell therapies against AbbVie-specified targets.

Fitbit Covid-19 Study Suggests Wearables Can Detect Disease Before Symptoms Arrive

Algorithms, Canada, Coronavirus Cases, Fitbit, Hospitalizations, R&D, Scripps Research Institute, Studies, Symptoms: Coronavirus Disease 2019 (COVID-19), United States, Wearables

A study of Fitbit wearers concludes that almost 50 percent of Covid-19 cases can be detected a day before enrollees in the study reported the onset of symptoms, and with 70 percent specificity.

Mutated COVID-19 Viral Strain in U.S. and Europe 10 Times More Contagious than Original Strain

ACE2 (angiotensin-converting enzyme-2), Asia, Cells, Coronavirus Disease 2019 (COVID-19), Europe, Genetic Mutations, Institutes, Mutations, Proteins, R&D, Researchers, Scripps Research Institute, Studies, United States

Researchers at the The Scripps Research Institute found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.